Buscar
Scisparc Ltd
SPRCAñadir a la lista de seguimiento
4.780USD
-0.370-7.18%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
2.56MCap. mercado
PérdidaP/E TTM
Más Datos de Scisparc Ltd Compañía
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Información de Scisparc Ltd
Símbolo de cotizaciónSPRC
Nombre de la empresaScisparc Ltd
Fecha de salida a bolsaDec 22, 2021
Director ejecutivoWeiss (Amitay)
Número de empleados2
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 22
Dirección20 Raul Wallenberg Street, Tower A
CiudadTEL AVIV-YAFO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIsrael
Código postal6971916
Teléfono97236103100
Sitio Webhttps://scisparc.com/
Símbolo de cotizaciónSPRC
Fecha de salida a bolsaDec 22, 2021
Director ejecutivoWeiss (Amitay)
Ejecutivos de Scisparc Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Itschak Shrem
Mr. Itschak Shrem
Chairman of the Board
Chairman of the Board
2.00
+50.00%
Mr. Amitay Weiss
Mr. Amitay Weiss
Chief Executive Officer, Director
Chief Executive Officer, Director
1.00
--
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Prof. Ari Shamiss, M.D.
Prof. Ari Shamiss, M.D.
Independent Director
Independent Director
--
--
Mr. Moshe Revach
Mr. Moshe Revach
Director
Director
--
--
Mr. Lior Vider
Mr. Lior Vider
Independent Director
Independent Director
--
--
Ms. Liat Sidi
Ms. Liat Sidi
Director
Director
--
--
Mr. Amnon Shay
Mr. Amnon Shay
Independent Director
Independent Director
--
--
Mr. Alon Dayan
Mr. Alon Dayan
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Itschak Shrem
Mr. Itschak Shrem
Chairman of the Board
Chairman of the Board
2.00
+50.00%
Mr. Amitay Weiss
Mr. Amitay Weiss
Chief Executive Officer, Director
Chief Executive Officer, Director
1.00
--
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Prof. Ari Shamiss, M.D.
Prof. Ari Shamiss, M.D.
Independent Director
Independent Director
--
--
Mr. Moshe Revach
Mr. Moshe Revach
Director
Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Scisparc Ltd?
Los cinco principales accionistas de Scisparc Ltd son: Mr. Itschak Shrem
¿Cuántas instituciones poseen acciones de Scisparc Ltd (SPRC)?
A fecha de 2026Q1, 17 instituciones poseen acciones de Scisparc Ltd, con un valor de mercado combinado de aproximadamente 6.67K, lo que representa el 1.16% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 2439.00.